These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35605028)

  • 1. APE1 shRNA-loaded cancer stem cell-derived extracellular vesicles reverse Erlotinib resistance in non-small cell lung cancer via the IL-6/STAT3 signalling.
    Tang CH; Qin L; Gao YC; Chen TY; Xu K; Liu T; Ren T
    Clin Transl Med; 2022 May; 12(5):e876. PubMed ID: 35605028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
    Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
    Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
    Ren T; Shan J; Qing Y; Qian C; Li Q; Lu G; Li M; Li C; Peng Y; Luo H; Zhang S; Zhang W; Wang D; Zhou SF
    Drug Des Devel Ther; 2014; 8():2517-29. PubMed ID: 25548514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1.
    Jiang ST; Han SY; Pang LN; Jiao YN; He XR; Li PP
    Int J Mol Med; 2018 Apr; 41(4):2128-2138. PubMed ID: 29393411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer.
    Lv T; Li Z; Xu L; Zhang Y; Chen H; Gao Y
    Acta Biomater; 2018 Aug; 76():257-274. PubMed ID: 29960010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Huanglian Jiedu Decoction and erlotinib delays growth and improves sensitivity of EGFR‑mutated NSCLC cells in vitro and in vivo via STAT3/Bcl‑2 signaling.
    Zhou X; Liu B; Ning Q; Xia Z; Zhong R; Zhang L; Wu L
    Oncol Rep; 2021 Jan; 45(1):217-229. PubMed ID: 33200228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells.
    Malanga D; De Marco C; Guerriero I; Colelli F; Rinaldo N; Scrima M; Mirante T; De Vitis C; Zoppoli P; Ceccarelli M; Riccardi M; Ravo M; Weisz A; Federico A; Franco R; Rocco G; Mancini R; Rizzuto A; Gulletta E; Ciliberto G; Viglietto G
    Oncotarget; 2015 Dec; 6(40):42667-86. PubMed ID: 26486080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer.
    Li R; Hu Z; Sun SY; Chen ZG; Owonikoko TK; Sica GL; Ramalingam SS; Curran WJ; Khuri FR; Deng X
    Mol Cancer Ther; 2013 Oct; 12(10):2200-12. PubMed ID: 23894143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer.
    Yang X; Peng Y; Jiang X; Lu X; Duan W; Zhang S; Dai N; Shan J; Feng Y; Li X; Cheng Y; Yang Y; Baugh L; Tell G; Wang D; Li M
    Cancer Med; 2018 Sep; 7(9):4406-4419. PubMed ID: 30109782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of signal transducer and activator of transcription 3 enhanceosome formation by apurinic/apyrimidinic endonuclease 1 in hepatic acute phase response.
    Ray S; Lee C; Hou T; Bhakat KK; Brasier AR
    Mol Endocrinol; 2010 Feb; 24(2):391-401. PubMed ID: 20032196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
    Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
    Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor.
    Zhao FY; Han J; Chen XW; Wang J; Wang XD; Sun JG; Chen ZT
    Int J Mol Med; 2016 Jul; 38(1):183-91. PubMed ID: 27177336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway.
    Han Z; Zhou X; Li S; Qin Y; Chen Y; Liu H
    Oncol Rep; 2017 Nov; 38(5):3064-3070. PubMed ID: 28901474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth.
    Xu L; Meng X; Xu N; Fu W; Tan H; Zhang L; Zhou Q; Qian J; Tu S; Li X; Lao Y; Xu H
    Cell Death Dis; 2018 Feb; 9(3):262. PubMed ID: 29449529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-ray irradiation in lung cancer cells.
    Gu X; Cun Y; Li M; Qing Y; Jin F; Zhong Z; Dai N; Qian C; Sui J; Wang D
    Int J Med Sci; 2013; 10(7):870-82. PubMed ID: 23781133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of non-small cell lung cancer metastasis by knocking down APE1 through regulating myeloid-derived suppressor cells-induced immune disorders.
    Zhang Z; Lin Y; Pan X; Chen S
    Aging (Albany NY); 2024 Jun; 16(12):10435-10445. PubMed ID: 38885059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of Epithelial-Mesenchymal Transition.
    Wei X; Li Q; Li Y; Duan W; Huang C; Zheng X; Sun L; Luo J; Wang D; Zhang S; Xin X; Gao M
    Oncotarget; 2016 May; 7(19):28523-39. PubMed ID: 27074577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knock down of the dual functional protein apurinic /apyrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model.
    Yang ZZ; Li MX; Zhang YS; Xiang DB; Dai N; Zeng LL; Li ZP; Wang G; Wang D
    Cancer Sci; 2010 Jan; 101(1):180-7. PubMed ID: 19860842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin.
    Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Segura-Carretero A; Joven J; Martin-Castillo B; Barrajón-Catalán E; Micol V; Bosch-Barrera J; Menendez JA
    Cell Cycle; 2013 Nov; 12(21):3390-404. PubMed ID: 24047698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.